Invention Grant
- Patent Title: Tetrahydroisoquinoline compound
- Patent Title (中): 四氢异喹啉化合物
-
Application No.: US12531318Application Date: 2008-04-03
-
Publication No.: US08273766B2Publication Date: 2012-09-25
- Inventor: Seiichi Sato , Junya Tagashira , Shunji Takemura , Yoshiharu Miyake , Tetsuya Ishikawa , Toshiharu Arai , Takahiro Ito , Takuya Hara
- Applicant: Seiichi Sato , Junya Tagashira , Shunji Takemura , Yoshiharu Miyake , Tetsuya Ishikawa , Toshiharu Arai , Takahiro Ito , Takuya Hara
- Applicant Address: JP Aichi
- Assignee: Kowa Company, Ltd.
- Current Assignee: Kowa Company, Ltd.
- Current Assignee Address: JP Aichi
- Agency: Greenblum & Bernstein, P.L.C.
- International Application: PCT/JP2008/056677 WO 20080403
- International Announcement: WO2008/123582 WO 20081016
- Main IPC: C07D217/18
- IPC: C07D217/18 ; A61K31/47
Abstract:
The present invention relates a specific tetrahydroisoquinoline compound which is useful as a chemokine receptor type 3 (CCR3) antagonist, and a pharmaceutical composition comprising the same as an active ingredient. The tetrahydroisoquinoline compound of the present invention is useful for the treatment or prevention of a disease in which CCR3 participates.
Public/Granted literature
- US20100120844A1 TETRAHYDROISOQUINOLINE COMPOUND Public/Granted day:2010-05-13
Information query
